LS

Laxman Sitaram Ufale

Active Director Director DIN 05341159
DIN 05341159 First appointment Jun 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 5 historical roles
Total affiliations 8 Since Jun 2013
Shareholding value •••• Premium profile

About Laxman Sitaram Ufale

Data last updated:

Laxman Sitaram Ufale is a Director at Spectrum Pharmaceuticals Private Limited (since 2023), Additional Director at Amaysr Laboratories Private Limited (since 2023) and Director at Krisp Laboratories Private Limited (since 2022). The companies operate in Pharma, Chemicals and Packaging. The 2 current companies with reported revenue have a combined latest revenue of ₹5.13 Cr; the largest is Spectrum Pharmaceuticals Private Limited at ₹5.12 Cr (FY 2025). Earlier, Laxman Sitaram Ufale was a Director at Glamour Canning Private Limited (2021–2022) and Director at Glamour Tin Industries Pvt Ltd (2021–2022) and 3 more.

DIN 05341159
Primary Designation Director
Industry Pharma
First Appointment 07 Jun 2013
Oldest Company Age 48 yrs
Largest company Spectrum Pharmaceuticals Private Limited · ₹5.12 Cr (FY 2025)
Combined revenue ₹5.13 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Oct 20231978₹5.12 Cr (FY 2025)Active
Amaysr Laboratories Private Limited U24299MH2019PTC333603
Additional Director30 Oct 20232019₹1.5 Lakh (FY 2024)Active
Krisp Laboratories Private Limited U99999MH1986PTC040344
Director08 Jul 20221986Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Glamour Canning Private Limited U28995MH2019PTC331706
Director16 Mar 20212019₹15 Lakh (FY 2025)Active
Glamour Tin Industries Pvt Ltd U99999MH1983PTC029905
Director16 Mar 20211983₹41.65 Cr (FY 2025)Active
Director13 Oct 20212021Active
The Equus Stud Pvt Ltd U01220MH1982PTC025998
Director07 Jun 20131982₹3.00 Cr (FY 2025)Active
Partner10 Jun 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Laxman Sitaram Ufale

Directorship timeline

Open interactive timeline →
Krisp Laboratories Private Limited
Spectrum Pharmaceuticals Private Limited
Amaysr Laboratories Private Limited
Glamour Canning Private Limited
Premium access

Shareholding and investment profile for Laxman Sitaram Ufale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Laxman Sitaram Ufale

Laxman Sitaram Ufale currently holds 3 directorships: Spectrum Pharmaceuticals Private Limited (Director, since 30 Oct 2023, revenue ₹5.12 Cr (FY 2025)); Amaysr Laboratories Private Limited (Additional Director, since 30 Oct 2023, revenue ₹1.5 Lakh (FY 2024)); Krisp Laboratories Private Limited (Director, since 08 Jul 2022).

Laxman Sitaram Ufale was first appointed on 07 Jun 2013 as Director at The Equus Stud Pvt Ltd. The most recent appointment on record is 30 Oct 2023 at Amaysr Laboratories Private Limited.

The 2 current companies of Laxman Sitaram Ufale that report revenue have a combined latest revenue of ₹5.13 Cr: Spectrum Pharmaceuticals Private Limited ₹5.12 Cr (FY 2025); Amaysr Laboratories Private Limited ₹1.5 Lakh (FY 2024).

Laxman Sitaram Ufale held 5 earlier board appointments: Glamour Canning Private Limited (Director, 16 Mar 2021 to 23 Jun 2022); Glamour Tin Industries Pvt Ltd (Director, 16 Mar 2021 to 23 Jun 2022); Clearline Diagnostic Centre Private Limited (Director, 13 Oct 2021 to 14 Jul 2022); The Equus Stud Pvt Ltd (Director, 07 Jun 2013 to 18 Mar 2021); Sunvalue Trading Llp (Partner, 10 Jun 2019 to 15 Nov 2021).

The current boards of Laxman Sitaram Ufale's companies include Anil Nivrutti Dumbre (Spectrum Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available